Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
PRKN - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Hereditary Parkinson Disease and Parkinsonism Panel Invitae United States | 44 | 26 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Parkinson Disease and Parkinsonism Panel PreventionGenetics, part of Exact Sciences United States | 68 | 70 |
|
PreventionGenetics, part of Exact Sciences United States | 27 | 24 |
|
Invitae Dystonia Comprehensive Panel Invitae United States | 61 | 38 |
|
Parkinson's Disease, Juvenile via the PRKN/PARK2 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Parkinson's disease panel. NGS panel of 22 genes. Genologica Medica Spain | 45 | 22 |
|
Parkinson deletion/duplication analysis Duzen Laboratories Duzen BBAGUAS Turkey | 8 | 8 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 1 | 1 |
|
Dystonia and Parkinsonism Panel GeneDx United States | 20 | 73 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Parkinson Disease: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 20 | 24 |
|
Parkinson Disease , Panel Massive Sequencing (NGS) 11 Genes Reference Laboratory Genetics Spain | 12 | 11 |
|
Dystonia and Related Disorders , Panel Massive Sequencing (NGS) 13 Genes Reference Laboratory Genetics Spain | 21 | 13 |
|
PARKINSON, RECESSIVE JUVENILE (PARK2) Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Parkinson Disease , Deletions-Duplications (MLPA) SNCA, PARK2, PINK1, PARK7, LRRK2, UCHL1 Genes Reference Laboratory Genetics Spain | 6 | 6 |
|
Parkinson Disease Type 2, Deletions-Duplications (MLPA) PRKN (PARK2) Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Parkinson Disease Type 2, Sequencing PRKN (PARK2) Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.